Management of malignant pleural effusion in Italian clinical practice: a nationwide survey
Background Pleural disease (PD), particularly malignant pleural effusion (MPE), is a common cause of hospital admission and its prevalence is rising worldwide.
Federico Mei +12 more
doaj +1 more source
Intraperitoneal chemotherapy for peritoneal metastases : an expert opinion
Introduction: The rationale for intraperitoneal (IP) drug delivery for patients with peritoneal metastases (PM) is based on the pharmacokinetic advantage resulting from the peritoneal-plasma barrier, and on the potential to adequately treat small, poorly
Braet, Helena +4 more
core +1 more source
Palliative treatment for symptomatic malignant pericardial effusion†. [PDF]
Consensus has yet to emerge regarding the optimal choice of therapy in the management of malignant pericardial effusion. We review the literature to evaluate the existing evidence on the clinical effectiveness of surgical and interventional cardiological
Bowden, Jack +3 more
core +1 more source
Silver Nitrate-Coated Versus Standard Indwelling Pleural Catheter for Malignant Effusions:The SWIFT Randomized Trial [PDF]
RATIONALE: Tunneled, indwelling pleural catheters (IPC) have been demonstrated to be an effective method of managing malignant pleural effusions. However, they allow pleurodesis and can therefore be removed in only a subset of patients.
Akulian, Jason +19 more
core +3 more sources
The open‐label randomized controlled trial evaluated the safety and efficacy of a disposable dry seal chest drainage (DSCD) system compared with single‐bottle water‐sealed drainage (SBWSD) after lobectomy. The DSCD system showed higher postoperative oxygen saturation levels (p < 0.001), a lower incidence of DVT (p = 0.032), and a substantially reduced ...
Lei Liu +9 more
wiley +1 more source
Indwelling pleural catheterization maximizes functionality and quality of life in management of recurrent malignant pleural effusions [PDF]
A clinical decision report using: Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: The TIME2 randomized controlled trial.
Ramkissoon, Avinash
core +2 more sources
Deep Vein Thrombosis in Critically Ill Patients With COVID‐19 Pneumonia
Objectives The risk of major venous thromboembolism (VTE) among patients with COVID‐19 is high but varies with disease severity. Estimate the incidence of lower extremity deep venous thrombosis (DVT) in critically ill hospitalized patients with COVID‐19, validate the Wells score for DVT diagnosis, and determine patients' prognosis.
Clévio Cezar da Fonseca +20 more
wiley +1 more source
Use of a hydrophilic coating wire reduces significantly the rate of central vein punctures and the incidence of pneumothorax in totally implantable access port (TIAP) surgery [PDF]
Background: Insertion of a Totally Implantable Access Port (TIAP) can be performed either via Central Vein Puncture (CVP) or Brachiocephalic Vein Cut-down (venous section-VS).
Bruckner, Thomas +7 more
core +1 more source
Background: Malignant pleural effusion (MPE) can cause dyspnea symptoms that greatly impact a patient's quality of life. Talc pleurodesis or indwelling pleural catheter (IPC) insertion are two treatment options that can prevent recurrent MPE, alleviate ...
Jitanong Sootlek
semanticscholar +1 more source
The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz +9 more
wiley +1 more source

